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ABSTRACT
Objective To evaluate whether implementation of the
Michigan Keystone ICU project, a comprehensive
statewide quality improvement initiative focused on
reductionofinfections,wasassociatedwithreductionsin
hospital mortalityand lengthof stay for adults aged65 or
more admitted to intensive care units.
Design Retrospective comparative study, using data from
Medicare claims.
Setting Michigan and Midwest region, United States.
Population The study period (October 2001 to December
2006) spanned two years before the project was initiated
to 22 months after its implementation. The study sample
included hospital admissions for patients treated in 95
study hospitals in Michigan (238937 total admissions)
comparedwith 364 hospitals in the surroundingMidwest
region (1091547 total admissions).
Main outcome measures Hospital mortality and length of
hospital stay.
Results The overall trajectory of mortality outcomes
differed significantly between the two groups upon
implementation of the project (Wald test χ
2=8.73,
P=0.033). Reductions in mortality were significantly
greater for the study groupthan for the comparison group
1-12 months (odds ratio 0.83, 95% confidence interval
0.79 to 0.87 v 0.88, 0.85 to 0.90, P=0.041) and
13-22 months (0.76, 0.72 to 0.81 v 0.84, 0.81 to 0.86,
P=0.007) after implementation of the project. The overall
trajectory of length of stay did not differ significantly
between the groups upon implementation of the project
(Wald test χ
2=2.05, P=0.560). Group differences in
adjusted length of stay compared with baseline did not
reach significance during implementation of the project
(−0.45 days, 95% confidence interval −0.62 to −0.28 v
−0.35, −0.52 to −0.19) or during post-implementation
months 1-12 (−0.59, −0.80 to −0.37 v −0.42, −0.59 to
−0.25) and 13-22 (−0.67, −0.91 to −0.43 v −0.54, −0.72
to −0.37).
Conclusions Implementation of the Keystone ICU project
was associated with a significant decrease in hospital
mortality in Michigan compared with the surrounding
area. The project was not, however, sufficiently powered
to show a significant difference in length of stay.
INTRODUCTION
The US Institute of Medicine highlighted the serious
problem of patient safety and importance of evidence
based quality improvement initiatives to reduce
adverse events.
1 Evidence that quality improvement
initiatives intended to reduce adverse events result in
a measurable impact on other important outcomes,
suchasmortalityandlengthofhospitalstay,islimited.
Withoutthisevidence,hospitalsandhealthcarepayers
face uncertainty about whether investment in any spe-
cific quality improvement intervention will signifi-
cantly benefit patients and represent a good use of
limited financial resources.
TheMichiganHealthandHospitalAssociationKey-
stone ICU (intensive care unit) project, developed by
researchers at Johns Hopkins and undertaken by the
Michigan Health and Hospital Association, about 80
ofits memberhospitals,and researchersatJohnsHop-
kins Medical Institutions, is a recent example of a suc-
cessful, large scale quality improvement initiative.
2-4
The project adopted a comprehensive approach to
improving patient safety that included promoting a
culture of safety, improving communication between
providers,andimplementingevidencebasedpractices
to reduce rates of catheter related bloodstream infec-
tions and ventilator associated pneumonia. Evidence
based interventions for preventing catheter related
bloodstream infections were promoting handwashing,
full barrier precautions, skin antisepsis with chlorhex-
idine, avoiding the femoral site during catheter inser-
tion, and removing unnecessary catheters.
Interventions to prevent ventilator associated pneu-
monia included a mechanical ventilator “bundle” con-
sisting of use of semirecumbent positioning, daily
interruption of sedation infusions, and prophylaxis
for peptic ulcer disease and deep venous thrombosis.
5
Theprojectshowedthatmeasuresofcultureandinfec-
tion rates in the intensive care unit were substantially
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quality improvement measures.
24-6
Although adverse events, such as catheter related
bloodstreaminfectionsandventilatorassociatedpneu-
monia, have been associated with increased patient
morbidity, mortality, and increased length of stay,
7-12
evidence that quality improvement initiatives lead to
significantreductions in theseoutcomes is limited. We
thereforeevaluatedchangesinstatewidehospitalmor-
tality and length of stay for Medicare patients in inten-
sive care units in Michigan hospitals compared with a
group of hospitals in the surrounding area.
METHODS
This research is a retrospective, observational com-
parative study with concurrent controls using Medi-
care claims data for patients aged 65 years or more
admittedtointensivecareunits.Weevaluatedwhether
mortality and length of stay for patients in intensive
care units changed after implementation of the Key-
stone ICU project in Michigan hospitals versus a com-
parison group of hospitals located in the surrounding
states in the US Midwest region.
The Keystone ICU project was initiated in October
2003 and all Michigan hospitals were invited to parti-
cipate. Beginning in March 2004, multiple quality
improvement interventions were sequentially imple-
mented in participating intensive care units. Seventy
seven hospitals submitted data for at least one compo-
nent of this initiative. The study period spanned Octo-
ber 2001 to December 2006, representing a start date
two years before the project was initiated and an end
date coincident with the latest available Medicare data
at the time of this analysis.
Althoughimplementationdatesvariedacrosshospi-
tals, most hospitals had implemented all interventions
within one year (March 2004 to February 2005). For
analysis we grouped data into six discrete periods:
baseline (12 months: October 2001 to September
2002), pre-implementation of the project (12 months:
October 2002 to September 2003), project initiation
(5 months: October 2003 to February 2004), imple-
mentation of the interventions (12 months: March
2004 to February 2005), 1-12 months post-implemen-
tation(12months:March2005toFebruary2006),and
13-22 months post-implementation (10 months:
March 2006 to December 2006). The periods were
selected a priori and correlated with phases of the
research project.
Study sample and setting
The study sample included all hospital admissions for
adults aged 65 or more. This group accounts for about
half of all patients in intensive care units
13 and such
patients are at increased risk for preventable adverse
events and their subsequentnegative effects on patient
outcomes.
1415 We limited analysis of hospital admis-
sions to those that included a stay in general, surgical,
medical, burns, or trauma intensive care units at an
eligible hospital, defined as a hospital with 50 or
more acute care beds and 200 or more total eligible
admissions to the intensive care unit during the entire
five years and three months of the study period. For
patientswithmultipleadmissionsduringthestudyper-
iod,weconsideredeachadmission(theunitofanalysis)
a unique event.
We used an intention to treat model to define the
studygroup. Assuch, the studygroup included admis-
sions with a stay in an intensivecare unit from all eligi-
ble hospitals in Michigan (regardless of their
participation in the Keystone ICU project) plus five
additionaloutofstatehospitalsaffiliatedwithhospitals
inMichiganthatparticipatedintheKeystoneICUpro-
ject. Unique Medicare provider identification num-
bers were available for 132 Michigan hospitals; 42 of
thesedidnotmeetthestudy’seligibilitycriteria,result-
ing in a total study group of 95 hospitals. Within the
study group, about 88% of hospital admissions in this
analysis came from 73 hospitals that submitted data to
the Keystone ICU project.
To control for potential confounding effects of
geography,
16 temporal trends in outcomes, and hospi-
tal characteristics, we used a concurrent control group
for comparison. This group consisted of all hospital
admissionswithanintensivecareunitstayfromhospi-
talslocatedacrosstheother11statesintheUSMidwest
region(asdefinedbytheUSCensusBureau),withhos-
pital selection based on a random sampling methodol-
ogy stratified by hospital bed size and teaching status
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initially selected 64% (n=631) of hospitals in the Mid-
west region for the comparison group, including all
large teaching, large non-teaching, and small teaching
hospitalsin the region.After exclusions,the final com-
parison group represented 37% (n=364) of Midwest
hospitals. The sample size calculation was conserva-
tively based on the number of hospitals, rather than
hospital admissions, because the analysis accounted
for clustering of admissions within hospitals. The sam-
ple size calculation assumed a power of 0.80, a two
tailed α of 0.05, detection of a difference in reduction
in length of stay between study and comparison group
hospitals of 0.1 days (group standard deviation 0.3),
and a fixed study group size of 90 hospitals (an initial
conservative estimate of the number of Michigan hos-
pitalsduringthestudyperiod),resultingina4:1ratioof
comparison to study group hospitals.
Data sources and study variables
For the analysis we used the dataset of the Medicare
Provider Analysis and Review (MEDPAR). This data-
setcontainsclaimssubmittedbyacutecarehospitalsto
the Centers for Medicare and Medicaid Services for
services provided to fee for service Medicare benefici-
aries, with reliable identification of stays in hospitals
and intensive care units. Each claim includes patient
demographic data, diagnoses and procedures, an
intensive care unit indicator, hospital mortality status
(defined as “death” for discharge location), and length
of stay. For this study we created categorical variables
forpatients’age(65-74,75-84,and≥85)andrace(white
and all other). We used diagnosis codes according to
ICD-9-CM (international classification of diseases,
ninth revision, clinical modification codes), cate-
gorised using the clinical classification software of the
Healthcare Cost and Utilization Project (18 level 1
categories)
17 and included as individual indicators in
the model. To adjust for patient case mix we also
included individual comorbidities using the Charl-
son-Deyo method.
18 To account for seasonality, we
used a variable identifying the three month period
(quarter)inwhichthepatientwasdischargedfromhos-
pital.
Hospital bed size and teaching status were obtained
from American Hospital Association statistics for
Table 1 |Characteristics of patients in Michigan hospitals and comparison hospitals. Values are numbers (percentages)
Characteristics
Study group* (n=238 937) Comparison group* (n=1 091 547)
Pre-implementation
(n=110 317)
Post-implementation
(n=128 620)
Pre-implementation
(n=517 804)
Post-implementation
(n=573 743)
Age (years):
65-74 45 277 (41) 52 629 (41) 211 749 (41) 231 685 (40)
75-84 47 214 (43) 54 134 (42) 220971 (43) 240451 (42)
≥85 17 826 (16) 21 957 (16) 85 084 (16) 101 607 (18)
Male 54 115 (49) 63 783 (50) 260 479 (50) 287 174 (50)
White race 93 918 (85) 110744 (86) 468 576 (90) 514 413 (90)
Charlson-Deyo comorbidity†:
Coronary heart failure 36 314 (33) 43 975 (34) 153 319 (30) 179 622 (31)
Chronic obstructive pulmonary disease 33 899 (31) 41 102 (32) 140 353 (27) 166 250 (29)
Diabetes 22 253 (20) 24 244 (19) 98 712 (19) 105 068 (18)
Acute myocardial infarction 23 019 (21) 23 718 (18) 101 918 (20) 98 404 (17)
Stroke 16 521 (15) 18 252 (14) 72 173 (14) 76 188 (13)
Primary diagnosis‡:
Diseases of the circulatory system 54 376 (49) 56 198 (44) 258 672 (50) 254 699 (44)
Diseases of the respiratory system 14 418 (13) 17 695 (14) 59 755 (12) 71 499 (12)
Diseases of the digestive system 10 041 (9) 12 168 (9) 47 951 (9) 56 488 (10)
Injury and poisoning 8555 (8) 11 363 (9) 45 688 (9) 55 408 (10)
Neoplasms 8461 (8) 10 290 (8) 39 690 (8) 44 549 (8)
Time of discharge:
Summer (Jun-Aug) 23 063 (21) 33 569 (26) 106 504 (21) 149 047 (26)
Autumn (Sep-Nov) 30 491 (28) 33 569 (26) 141 538 (27) 148 574 (26)
Winter (Dec-Feb) 33 724 (31) 26 111 (20) 160 224 (31) 117 237 (20)
Spring (Mar-May) 23 039 (21) 35 011 (27) 109 538 (21) 158 885 (28)
Percentages may not add to 100% owing to rounding.
*Study periods were collapsed into pre-implementation and post-implementation periods for comparison purposes. Pre-implementation include the
following study periods: baseline (hospital admissions in study and comparison groups 19% and 20%, respectively), pre-implementation (19% and
20%), and project initiation (8% each); and post-implementation include the following study periods: implementation (19% each), 1-12 months post-
implementation (19% each), and 13-22 months post-implementation (16% and 15%).
†Top five (out of 17) most common comorbidities are presented. Percentages do not add to 100% as comorbidities are not mutually exclusive. The
remaining comorbidities have overall frequencies of <11%.
‡Top five (out of 18) most common clinical classification level 1 categories from Healthcare Cost and Utilization Project are presented, which
represent about 86% of all patients.
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elled hospital size as a categorical variable: 50-199,
200-299, 300-399, >400 beds.
26Hospitals were classi-
fied as teaching if residency training was approved by
the Accreditation Council for Graduate Medical Edu-
cation or American Osteopathic Association, or the
hospital was a member of the Council of Teaching
HospitalsoftheAssociationofAmericanMedicalCol-
leges. We classified hospitals as urban if they were
located in a metropolitan statistical area, as defined
by the US Census Bureau. We combined variables
for teaching and urban status into one variable com-
prising four categories: teaching and urban, teaching
and non-urban, non-teaching and urban, and non-
teachingandnon-urban.Informationonhospitalown-
ership (government, proprietary, non-profit) was
obtained from the Medicare cost reports.
Statistical analyses
We used multivariable logistic and Poisson (identity
link) regression models to evaluate the admissions
level adjusted odds of hospital mortality and adjusted
mean length of stay for each of the five study periods
compared with baseline, for both study and compari-
songroups.Themodelsincludedanindicatorforstudy
versuscomparisongroup,eachofthefivenon-baseline
periods (pre-implementation, projectinitiation, imple-
mentation, and post-implementation months 1-12 and
13-22),andtheinteractionsofthegroupindicatorwith
these periods. We used a Wald test to evaluate the glo-
bal significance of differences between the groups in
the trajectory of outcomes upon implementation of
the initiative (interaction terms for group by imple-
mentation and two post-implementation periods).
Allregressionmodelswereadjustedforpatientvari-
ables (age, sex, race, primary diagnosis, Charlson-
Deyo comorbidities, season of discharge) and hospital
variables (bed size, teaching and urban status,
ownership).We usedgeneralisedestimatingequations
to account for clustering of hospital admissions within
hospitals. In addition, the Poisson models allowed for
over-dispersion by scaling the standard errors using
the Pearson statistic. In our analysis of length of stay,
we used the observed length of stay for all patients,
including those who died during admission, as it is
the observed length of stay that is of relevance to
most stakeholders when considering the utilisation of
resources.Weobtainedunadjustedandadjustedpopu-
lation level mortality rates and average length of stay
duringeachstudytimeintervalforeachgroupfromthe
logistic and Poisson regression analyses, respectively,
using the mean of predicted probabilities method.
19
The models used in the analysis can influence
results.Totestwhethertheresultswere robusttoalter-
native models, we carried out sensitivity analyses
accounting for patients with multiple admissions (by
including index hospital admissions only) and hospi-
tals that closed or opened during the study period
(defined as a hospital contributing no patients to the
dataset during the first or last period). We also
exploredwhether findingswere sensitive to increasing
degrees of patient level adjustment for case mix (from
lowest to highest levels of adjustment, models
included:Charlson-Deyoindexandsurgicalandmed-
ical dichotomy for primary diagnosis, Charlson-Deyo
individual comorbidities and surgical and medical
dichotomy for primary diagnosis, and final model:
Charlson-Deyo individual comorbidities and Health-
care Cost and Utilization Project clinical classification
categoriesforprimarydiagnosis).Althoughwebelieve
that hospital mortality would more closely reflect the
impact of this intensive care unit based patient safety
initiative,wealsoranthemodelusing30daymortality
as the outcome variable (death dates were obtained
from the Medicare denominator file). We also carried
out a sensitivity analysis for length of stay excluding
patients who died during admission.
SAS software, version 9.1 was used for all analyses.
WeconsideredatwosidedPvalue<0.05assignificant.
RESULTS
Patient characteristics for hospital admissions were
similar for both the study group and the comparison
group (n=238937 and n=1091547, respectively) and
the pre-implementation and post-implementation per-
iods(table 1).The95studyhospitalshadahigherpro-
portion of hospitals with fewer than 200 beds and of
non-teaching and non-urban status than the 364 com-
parison hospitals (table 2). The figure presents the
population level unadjusted and adjusted mortality
rates and average length of stay over the study period
by group.
Adjusted hospital mortality
The overall trajectory of mortality differed signifi-
cantly between the study and comparison groups
upon implementation of the initiative (Wald test
χ
2=8.73,P=0.033).Comparedwiththebaselineperiod,
mortalitydidnotdiffersignificantlyforthestudygroup
Table 2 |Characteristics of Michigan hospitals and comparison hospitals. Values are numbers
(percentages)
Characteristics Study group* (n=95) Comparison group (n=364)
Hospital bed size:
50-199 45 (47) 153 (42)
200-299 19 (20) 72 (20)
300-399 16 (17) 60 (17)
≥4 0 0 1 5( 1 6 ) 7 9( 2 2 )
Hospitalteachingandurbanstatus†:
Teaching and urban 41 (43) 169 (46)
Teaching and non-urban 3 (3) 18 (5)
Non-teaching and urban 23 (24) 117 (32)
Non-teaching and non-urban 25 (26) 60 (17)
Hospital ownership:
Non-profit 83 (87) 293 (81)
Proprietary 3 (3) 26 (7)
Government 9 (10) 45 (12)
*Five hospitals were located outside of Michigan but affiliated with hospitals in Michigan that participated in
Keystone ICU project.
†Urban and non-urban location was not available for three study group hospitals (3.2%).
Percentages may not add to 100% owing to rounding.
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ods: pre-implementation (odds ratio 0.98, 95% confi-
dence interval 0.94 to 1.01 v 0.96, 0.95 to 0.98,
P=0.373), project initiation (0.97, 0.92 to 1.01 v 0.97,
0.94 to 0.99, P=0.981), and implementation periods
(0.89, 0.86 to 0.93 v 0.91, 0.89 to 0.93, P=0.513).
Reductions in mortality were significantly greater for
the study group than for the comparison group during
post-implementation months 1-12 (0.83, 0.79 to 0.87 v
0.88, 0.85 to 0.90, P=0.041) and 13-22 (0.76, 0.72 to
0.81 v 0.84, 0.81 to 0.86, P=0.007; table 3).
Adjusted length of hospital stay
The difference in overall trajectory of length of stay
was not significant between the study groups upon
implementation of the initiative (Wald test χ
2=2.05,
P=0.560).Comparedwithbaseline,theadjustedlength
of stay did not differ significantly between the study
group versus comparison group during the pre-imple-
mentationperiod(−0.06days,95%confidenceinterval
−0.20 to 0.08 v −0.15, −0.22 to −0.08, P=0.278) and
project initiation (−0.10, −0.38 to 0.02 v −0.10, −0.23
to 0.04, P=0.494). Although group differences in
adjusted length of stay compared with baseline were
greater for the study group they did not reach signifi-
cance during either the implementation period (−0.45,
−0.62 to −0.28 v −0.35, −0.52 to −0.19, P=0.429) or the
post-implementation months 1-12 (−0.59, −0.80 to
−0.37 v −0.42, −0.59 to −0.25, P=0.219) and 13-22
(−0.67, −0.91 to −0.43 v −0.54, −0.72 to −0.37,
P=0.401; table 4). The sample size (although large)
wasinsufficienttodetecttheoriginallyprojecteddiffer-
enceof0.1daysinreductionsinlengthofstaybetween
groups because the observed variation in the data was
about double that proposed in the sample size calcula-
tion. Therefore, the study was underpowered to con-
clusively show whether length of stay differed
significantly.
Sensitivity analyses
As some patients had multiple admissions shortly
before death (1.9% of patients during the baseline per-
iod), estimates for hospital mortality may be
conservative. However, sensitivity analyses account-
ing for patients with multiple recent admissions (by
excluding non-index admissions within a 30 day per-
iod) or including only a single index admission per
patient over the entire study period, did not change
the results. Also, no changes were observed when
excluding hospitals that may have opened or closed
during the study period. Treatment effects for hospital
mortality became more pronounced as we increased
levels of adjustment for patient case mix. When
30 day mortality rather than in-hospital mortality was
used as the outcome variable, results trended in the
hypothesised direction for the post-implementation
periods but did not reach statistical significance
(Wald test χ
2=5.51, P=0.138). For both study groups,
patients who died after being discharged from the hos-
pital (within 30 days of admission) were older (>
84 years) and had more comorbidities than patients
whodiedduringtheirhospitalstay.Excludingpatients
who died during their hospital stay did not the change
the findings for length of stay.
DISCUSSION
Implementation of the statewide Keystone ICU pro-
ject was associated with a significant reduction in hos-
pital mortality in Michigan compared with the
surroundingMidwestregion.Evidencetoconclusively
showasignificantchangeinhospitallengthofstaywas
insufficient, but the magnitude of the observed differ-
ence, had it been statistically significant, possibly
would be considered a clinically important difference.
These results may be conservative, as an intention to
treat model was used and all Michigan hospitals were
includedinthestudygroupdespiteonly77%(73outof
95) actually participating and contributing data in the
project. These findings suggest that investment in suc-
cessful, large scale, robust quality improvement initia-
tivesmaynotonly reduceadverseeventsandimprove
quality of care but also save lives.
Improvements in adjusted hospital mortality
increased over time in the study group during the two
post-implementation(1-12and13-22months)periods.
This finding has several possible explanations. Firstly,
Table 3 |Adjusted odds ratios for mortality in Michigan hospitals and comparison hospitals
Study period
Adjusted odds ratio* (95% CI) Study group v comparison group
Study group Comparison group P value† Wald test‡
Pre-implementation 0.98 (0.94 to 1.01) 0.96 (0.95 to 0.98) 0.373
—
Project initiation 0.97 (0.92 to 1.01) 0.97 (0.94 to 0.99) 0.981
Implementation 0.90 (0.86 to 0.93) 0.91 (0.89 to 0.93) 0.513
χ
2=8.73, P=0.033
Post-implementation:
1-12 months 0.83 (0.79 to 0.87) 0.88 (0.85 to 0.90) 0.041
13-22 months 0.76 (0.72 to 0.81) 0.84 (0.81 to 0.86) 0.007
*Adjusted odds ratios compare odds of death for period of interest to each group’s baseline period and were calculated using logistic regression
analysis. Analyses were adjusted for age, sex, race, primary diagnosis (using Healthcare Cost and Utilization Project clinical classification level 1
categories), Charlson-Deyo comorbidities, time of discharge, hospital bed size, hospital teaching and urban status, hospital ownership, with
generalised estimating equations with robust variance estimation to adjust for clustering of patient admissions within hospitals.
†P values for test of equality of study and comparison group effects were obtained from interaction terms for group and time period indicators.
‡Wald test used to test global significance of differences between study and comparison groups in trajectory of mortality upon implementation of
initiative (interaction terms for group by implementation and two post-implementation periods).
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taken time to realise, as was suggested by the steadily
decreasingratesforcatheterrelatedbloodstreaminfec-
tion over the first six quarters (18 months) after imple-
mentationoftheintervention.
2Secondly,aspartofthe
initiative included changing culture and teamwork,
these elements take longer to improve and may be
expected to provide a foundation for sustained efforts
and other benefits, as well as create a climate that
encourages continued quality improvement. Finally,
building on its initial success, the Michigan Health
and Hospital Association began implementing addi-
tional quality improvement initiatives during the
post-implementation period that may have improved
mortality. Despite these additional initiatives, a trend
indicatingamortalitybenefitwasfirstobservedduring
the implementation period, supporting the impact of
the Keystone ICU project on mortality.
Limitations of the study
Although this study provides important new data on
theimpactofalargescalequalityimprovementproject
onhospitalmortalityandlengthofstay,ithaspotential
limitations. Firstly, these findings cannot definitively
attributethemortality benefittothisinitiative,particu-
larly given the non-randomised study design and the
othersubsequenteffortstoimprovequalityandpatient
safety.However,nootherknownlargescaleinitiatives
were introduced across Michigan during the imple-
mentation period, and inclusion of a large and diverse
comparison group excluded region specific temporal
trends or national quality improvement efforts as an
explanation for the findings. Differential trends
between the study and comparison groups on changes
intheuseoflongtermacutecarefacilities,useofskilled
nursing facilities, number of intensive care unit beds,
transfersbetweenhospitals,ratesofelectivesurgery,or
discharge practices over the study period may have
contributed to the findings observed. Secondly, Medi-
careProviderAnalysisandReviewisanadministrative
billing database for Medicare. As a result, miscoding
may occur and residual confounding may exist for dif-
ferences in patient case mix. However, there are no
data to suggest large scale differences in coding or
patient case mix over time or between the two groups
during the study period. Furthermore, this dataset
includes about half of all patients in intensive care
units
13withreliableidentificationofhospitalandinten-
sive care unit stay. Thirdly, generalisability of study
findings may be limited to patients aged 65 or more;
however, these patients represent about half of all
patients in intensive care units.
13 Also, findings from
this study may not be generalisable to hospitals with
fewer than 50 beds.
Finally, as the project is a multifaceted quality
improvement initiative with multiple interventions,
the observed benefits cannot be attributed to specific
components of the project. For example, the relative
importance of the Comprehensive Unit Based Safety
Program(the programmeusedtoimprove cultureand
teamwork)ortheincreaseduseofevidencebasedprac-
tices is unknown. However, given the low costs and
risks,webelievethatallcomponents,alongwithrobust
measurement and feedback of results, may act syner-
gistically and should be implemented together. Cen-
tralised and standardised measurement and evidence
basedinterventions,localmodificationandimplemen-
tation, adequate support, as well as hospital and staff
readinesstoengageineffortstochange,maybecritical
factors to yielding similar success in other settings.
20
Indeed,thecombinedinterventionisnowbeingimple-
mentednationwideandinseveralothercountries,with
these factors given important consideration.
Comparison with other studies
Evaluations of quality improvement interventions
intended to reduce infections often measure infection
rates directly but rely on estimates from literature on
cost of illness to calculate potential savings for mortal-
ity and length of stay.
21-23 However, estimates of sav-
ings vary widely owing to variations in study settings,
populations, and methods for adjustment of case
mix.
7-12 Since cost of illness studies compare outcomes
for patients with and without infections, the extent to
whichadjustmentforcasemixsufficientlyaccountsfor
underlying differences in patient populations is
Table 4 |Adjusted change in hospital length of stay for Michigan hospitals and comparison hospitals
Study periods
Adjusted change in length of stay* (95% CI) Study group v comparison group
Study group Comparison group P value for difference† Wald test‡
Pre-implementation −0.06 (−0.20 to 0.08) −0.15 (−0.22 to −0.08) 0.278
—
Project initiation −0.10 (−0.38 to 0.02) −0.10 (−0.23 to 0.04) 0.494
Implementation −0.45 (−0.62 to −0.28) −0.35 (−0.52 to −0.19) 0.429
χ
2=2.05, P=0.560
Post-implementation:
1-12 months −0.59 (−0.80 to −0.37) −0.42 (−0.59 to −0.25) 0.219
13-22 months −0.67 (−0.91 to −0.43) −0.54 (−0.72 to −0.37) 0.401
*Change in length of stay (days) from each group’s baseline period to period of interest, calculated using Poisson regression analysis. Analyses were
adjusted for age, sex, race, primary diagnosis (using Healthcare Cost and Utilization Project clinical classification level 1 categories), Charlson-Deyo
comorbidities (comorbidities with <15% frequency were excluded), time of discharge, hospital bed size, hospital teaching and urban status, hospital
ownership, with use of generalised estimating equations for clustering of patient admissions within hospitals.
†P values obtained from interaction terms for group and time period indicators.
‡Wald test used to test global significance of differences between study and comparison groups in trajectory of length of stay upon implementation
of the initiative (interaction terms for group by implementation and two post-implementation periods).
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length of stay from efforts to reduce the rate of infec-
tions,hospitalsand healthcarepayersmay besceptical
of the potential benefits of investing in quality
improvementinitiatives.Thisstudy’sfindingsarecon-
sistentwithpreviousliteraturereportingexcessmortal-
ity associated with catheter related bloodstream
infections and ventilator associated pneumonia in the
intensive care unit setting.
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Conclusions
Implementation of the statewide Keystone ICU pro-
jectwas associatedwitha significantdecrease in hospi-
tal mortality in Michigan compared with the
surrounding region. Owing to an insufficient sample
size, evidence on whether reductions in length of stay
observed in Michigan significantly differed from the
surrounding region was inconclusive. Given the rela-
tivelylowcost,thedecreasedrateofinfections,andthe
lack of any known negative effects of the quality
improvement initiative, these results strongly support
governments’, hospitals’, and healthcare payers’
investment in similar successful, large scale, robust
quality improvement initiatives to maximise patient
benefits.
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WHAT IS ALREADY KNOWN ON THIS TOPIC
Quality improvement initiatives have shown reductions in hospital acquired infections, but
their impact on other important outcomes is poorly understood
WHAT THIS STUDY ADDS
Reductions in hospital mortality for Medicare patients in the intensive care unit were
significantafterimplementationofacomprehensivestatewidequalityimprovementinitiative
in Michigan
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